Starbucks (SBUX) is ready to brew changes under the leadership of CEO Brian Niccol, who emphasized during the company’s earnings call on Oct. 30 that he believes the coffee giant’s problems are fixable.

Read more...

Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster weight loss drug Zepbound was not dragging down sales. Pfizer sales rose 31% to $17.7 billion in the third quarter of 2024, driven by a surge in demand for the pharma giant’s COVID-19 medications.…

Read more...

McDonald’s famously unreliable McFlurry machines might be a thing of the past following a recent court filing. Starbucks is saying goodbye to its olive oil-infused beverages as it aims to streamline its menu. Target’s challenging retail rivals Walmart and Aldi with a super cheap Thanksgiving basket. Check out those…

Read more...